SHENZHEN, China - TelAve -- At the start of the new year, Transtek Medical (300562.SZ) celebrates a double victory. On February 6, at the 2025 High-Quality Development Conference in Zhongshan Torch Development Zone, Transtek Medical was honored with two prestigious awards—"Top 10 Enterprises in R&D Investment Contribution" and the "Bai Qian Wan Project Contribution Award"—in recognition of its outstanding technological innovation and contributions to social and economic development.

Transtek Medical Recognized as a Top 10 Enterprise in R&D Investment Contribution

This award recognizes enterprises for their outstanding commitment to R&D investment. In addition to its headquarters in Zhongshan, Transtek Medical has established R&D centers in Shenzhen, Shanghai, and other locations. This continuous investment in R&D not only strengthens the company's core competitiveness but also provides strong support for regional economic innovation and development.

More on TelAve News

• 3E Launches First AI Agent Designed to Respond with Empathy for College Recruitment
• Security Alert: TZNXG Warns Investors About "Fund Recovery" Scams
• Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
• KatalisCoin: "Too Secure" for Bad Actors - Platform Embraces "Excessive Compliance" Criticism
• Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges

Transtek Medical Honored with the "Bai Qian Wan Project Contribution Award

This award was established as part of Guangdong Province's initiative to promote regional coordination, urban-rural integration, and industrial upgrading. It recognizes enterprises that have made outstanding contributions to local economic growth, industrial transformation, and rural revitalization. Transtek Medical actively fulfills its social responsibility, demonstrating strong corporate commitment and playing a key role in driving high-quality regional economic development.

Receiving both the "Top 10 Enterprises in R&D Investment Contribution" and the "Bai Qian Wan Project Contribution Award" at the 2025 High-Quality Development Conference in the Torch Development Zone is not only a strong recognition of Transtek Medical's outstanding past performance but also a testament to the high expectations for its future growth.

Founded in 2000, Transtek is committed to multiple health fields such as remote health and chronic disease management, providing customers with medical-grade "RPM devices" and "cloud services". Transtek also provides one-stop connectivity technology, device management, and fulfillment services for Remote Patient Monitoring (RPM) providers. Transtek has established a co-branded solution named TeleRPM since 2019, it stands for Quality & Value which is the best of Transtek. TeleRPM is an integrated solution which includes cellular blood pressure monitor, cellular weight scale, cellular blood glucose meter and all-round BLE package with AnyHub solution. Also, TeleRPM is open and scalable, and Transtek will leverage their expertise to help customers realize greater value, potential and outcomes.

More on TelAve News

• TSWHZC Platform Combines Automated Portfolio Management with Proof of Reserves for Brazil Market Entry
• AureaVault Positions Digital Asset Infrastructure for Shifting Monetary Policy Environment
• JQRBT Unveils High-Speed Trading Infrastructure Designed for Growing Institutional Crypto Market
• New Leadership and Renovations Usher in Next Chapter for Sunrise Manor
• Who Will Win the 2025 WNBA Finals? OddsTrader Shares Live Betting Odds and Projections